Angeles Wealth Management’s Globus Medical GMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$466K Buy
5,894
+280
+5% +$23.8K 0.02% 287
2026
Q1
$484K Buy
5,614
+498
+10% +$44.7K 0.03% 237
2025
Q4
$447K Buy
5,116
+83
+2% +$6.3K 0.02% 230
2025
Q3
$288K Sell
5,033
-6
-0.1% -$346 0.02% 265
2025
Q2
$297K Buy
5,039
+1,389
+38% +$89.7K 0.02% 260
2025
Q1
$267K Buy
3,650
+659
+22% +$54.5K 0.02% 240
2024
Q4
$247K Buy
+2,991
New +$236K 0.02% 252

Other funds holding GMED

Angeles Wealth Management's GMED Position: Q2 2026 in Review

Angeles Wealth Management increased its Globus Medical (GMED) stake by 5% in Q2 2026, buying an estimated $23.8K and bringing the position to 5,894 shares worth $466K. The position accounts for 0.02% of the portfolio, ranked #287.

Angeles Wealth Management first reported a position in GMED in Q4 2024 and has held it in 7 quarters since. The position peaked at $484K in Q1 2026. 599 funds tracked by Wall St. Rank hold GMED as of Q2 2026.

  • Angeles Wealth Management held 5,894 shares of Globus Medical worth $466K as of Q2 2026.
  • Angeles Wealth Management bought 280 Globus Medical shares in Q2 2026, an estimated $23.8K.
  • Globus Medical made up 0.02% of Angeles Wealth Management's portfolio in Q2 2026, its #287 holding.
  • Angeles Wealth Management first reported a position in Globus Medical in Q4 2024 and has held it in 7 quarters since.
  • Angeles Wealth Management's Globus Medical position peaked at $484K in Q1 2026.
  • 599 funds tracked by Wall St. Rank held Globus Medical as of Q2 2026.

Based on Angeles Wealth Management's 13F filing for Q2 2026, filed 28 Jul 2026.